Yale University Cancer Center — New Haven, Connecticut

Yale University Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Yale University Cancer Center has participated in 14 clinical trials with 8 currently active.

Therapeutic areas: Metastatic Breast Cancer, Bladder Cancer, Squamous Cell Carcinoma of the Lung.

Sponsors: Gilead Sciences, EvolveImmune United, Inc, Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University Cancer Center?

Yale University Cancer Center has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University Cancer Center conducted?

Yale University Cancer Center has 14 clinical trials on record, with 8 currently active. Their work covers Metastatic Breast Cancer, Bladder Cancer, Squamous Cell Carcinoma of the Lung.

Is Yale University Cancer Center accredited by Crixeo Health?

Yale University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.